201 related articles for article (PubMed ID: 26419344)
1. In vitro methods for screening transdermal formulations.
Tsai PC; Lee S; Michniak-Kohn B
Ther Deliv; 2015; 6(9):1043-52. PubMed ID: 26419344
[TBL] [Abstract][Full Text] [Related]
2. The transdermal revolution.
Thomas BJ; Finnin BC
Drug Discov Today; 2004 Aug; 9(16):697-703. PubMed ID: 15341783
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in dermal/transdermal delivery.
Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
[TBL] [Abstract][Full Text] [Related]
4. Ask the experts: transdermal drug delivery.
Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
[TBL] [Abstract][Full Text] [Related]
5. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
Ita KB
Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
[TBL] [Abstract][Full Text] [Related]
6. Innovations in transdermal drug delivery: formulations and techniques.
Tiwary AK; Sapra B; Jain S
Recent Pat Drug Deliv Formul; 2007; 1(1):23-36. PubMed ID: 19075872
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
8. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
Perumal O; Murthy SN; Kalia YN
Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
[TBL] [Abstract][Full Text] [Related]
10. Transdermal drug delivery.
Guy RH
Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in transdermal sonophoresis.
Ita K
Pharm Dev Technol; 2017 Jun; 22(4):458-466. PubMed ID: 26608060
[TBL] [Abstract][Full Text] [Related]
12. Vesicles as tools for the modulation of skin permeability.
Dubey V; Mishra D; Nahar M; Jain NK
Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
[TBL] [Abstract][Full Text] [Related]
13. Discovery of transdermal penetration enhancers by high-throughput screening.
Karande P; Jain A; Mitragotri S
Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
[TBL] [Abstract][Full Text] [Related]
14. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
15. [Transdermal therapeutic systems].
Losenkova SO
Eksp Klin Farmakol; 2008; 71(6):54-7. PubMed ID: 19140519
[TBL] [Abstract][Full Text] [Related]
16. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
17. Navigating sticky areas in transdermal product development.
Strasinger C; Raney SG; Tran DC; Ghosh P; Newman B; Bashaw ED; Ghosh T; Shukla CG
J Control Release; 2016 Jul; 233():1-9. PubMed ID: 27117457
[TBL] [Abstract][Full Text] [Related]
18. Themed issue: Recent advances in transdermal drug delivery.
Jones DS; Moss GP
J Pharm Pharmacol; 2010 Jun; 62(6):669-70. PubMed ID: 20636852
[No Abstract] [Full Text] [Related]
19. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
[TBL] [Abstract][Full Text] [Related]
20. Advances in the bioanalytical study of drug delivery across the skin.
Depieri LV; Praça FS; Campos PM; Bentley MV
Ther Deliv; 2015; 6(5):571-94. PubMed ID: 26001174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
